2019 annual financial data
Karyopharm Therapeutics 2019 Operating margin
Karyopharm Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -462.85%.
Operating income was -189,275,000 USD and net income was -199,590,000 USD.
Operating cash flow was -190,822,000 USD.
Get free Karyopharm Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,893,000 USD
- Operating income
- -189,275,000 USD
- Net income
- -199,590,000 USD
- Operating cash flow
- -190,822,000 USD